Cargando…

Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells

Cancer and other cells residing in the same niche engage various modes of interactions to synchronize and to buffer the negative effects of environmental changes. Extracellular miRNAs have been recently implicated in the intercellular crosstalk. Here we show a mechanistic model involving breast-canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Wei, Wu, Xiwei, Zhou, Weiying, Fong, Miranda Y., Cao, Minghui, Liu, Juan, Liu, Xiaojing, Chen, Chih-Hong, Fadare, Oluwole, Pizzo, Donald P., Wu, Jiawen, Liu, Liang, Liu, Xuxiang, Chin, Andrew R., Ren, Xiubao, Chen, Yuan, Locasale, Jason W., Wang, Shizhen Emily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920728/ https://www.ncbi.nlm.nih.gov/pubmed/29662176 http://dx.doi.org/10.1038/s41556-018-0083-6

Ejemplares similares

Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts
por: Liu, Xuxiang, et al.
Publicado: (2018)

Breast cancer-secreted miR-122 reprograms glucose metabolism in pre-metastatic niche to promote metastasis
por: Fong, Miranda Y., et al.
Publicado: (2015)

Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB
por: Chow, Amy, et al.
Publicado: (2014)

Cancer-cell-secreted Extracellular Vesicles Suppress Insulin Secretion through miR-122 to Impair Systemic Glucose Homeostasis and Contribute to Tumour Growth
por: Cao, Minghui, et al.
Publicado: (2022)

KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
por: Li, Jie, et al.
Publicado: (2018)

In vivo Reprogramming of Cancer Metabolism by MYC
por: Camarda, Roman, et al.
Publicado: (2017)

Tumor metabolic reprogramming in lung cancer progression
por: Li, Xin, et al.
Publicado: (2022)

Transforming growth factor β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM
por: Wang, Yujun, et al.
Publicado: (2010)

Uterine PEComa: appraisal of a controversial and increasingly reported mesenchymal neoplasm
por: Fadare, Oluwole
Publicado: (2008)

Digital Histology: An Interactive CD Atlas with Review Text
por: Fadare, Oluwole
Publicado: (2003)

Dysplastic Ichthyosis Uteri-like changes of the entire endometrium associated with a squamous cell carcinoma of the uterine cervix
por: Fadare, Oluwole
Publicado: (2006)

Uncommon sarcomas of the uterine cervix: a review of selected entities
por: Fadare, Oluwole
Publicado: (2006)

A Case of Extrauterine Endometrial Stromal Sarcoma in the Colon Diagnosed Three Decades after Hysterectomy for Benign Disease
por: Ayuso, Andres, et al.
Publicado: (2013)

Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2023)

Metabolomics reveals intratumor heterogeneity – Implications for precision medicine
por: Liu, Xiaojing, et al.
Publicado: (2017)

MYC-induced reprogramming of glutamine catabolism supports optimal virus replication
por: Thai, Minh, et al.
Publicado: (2015)

The impact of exosomes derived from distinct sources on rheumatoid arthritis
por: Zhang, Sicheng, et al.
Publicado: (2023)

c‐Myc–IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming
por: Zhang, Qiang, et al.
Publicado: (2023)

Hyperoxia induces glucose metabolism reprogramming and intracellular acidification by suppressing MYC/MCT1 axis in lung cancer
por: Liu, Xiucheng, et al.
Publicado: (2023)

Fatty acid synthase reprograms the epigenome in uterine leiomyosarcomas
por: Guan, Min, et al.
Publicado: (2017)

Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts
por: Heffernan, Corey, et al.
Publicado: (2012)

Development and Quantitative Evaluation of a High-Resolution Metabolomics Technology
por: Liu, Xiaojing, et al.
Publicado: (2014)

Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers
por: Fadare, Oluwole, et al.
Publicado: (2008)

Synchronously diagnosed pre-sacral neurofibroma and cutaneous spitzoid melanoma: a fortuitous association?
por: Fadare, Oluwole, et al.
Publicado: (2004)

p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry
por: Fadare, Oluwole, et al.
Publicado: (2017)

High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival
por: Yi, Shuhua, et al.
Publicado: (2015)

miR-22 Suppresses EMT by Mediating Metabolic Reprogramming in Colorectal Cancer through Targeting MYC-Associated Factor X
por: Xia, Shusen, et al.
Publicado: (2022)

Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib
por: Cao, Yang, et al.
Publicado: (2021)

Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels
por: Zhou, Chenfei, et al.
Publicado: (2021)

Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels
por: Zhou, Chenfei, et al.
Publicado: (2022)

Mucocele-like tumor and columnar cell hyperplasia of the breast occurring in a morphologic continuum
por: Fadare, Oluwole, et al.
Publicado: (2008)

Anti-Ri antibodies associated with short-term memory deficits and a mature cystic teratoma of the ovary
por: Fadare, Oluwole, et al.
Publicado: (2004)

Adenoid basal lesions of the uterine cervix: evolving terminology and clinicopathological concepts
por: Russell, Michael J, et al.
Publicado: (2006)

Dedifferentiated Leiomyosarcoma of the Uterus with Heterologous Elements: A Potential Diagnostic Pitfall
por: Rawish, Kojo R., et al.
Publicado: (2012)

BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming
por: Kim, Esther J.Y., et al.
Publicado: (2018)

MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming
por: Prieto, Javier, et al.
Publicado: (2018)

Caveolin-1 inhibits breast cancer stem cells via c-Myc-mediated metabolic reprogramming
por: Wang, Shengqi, et al.
Publicado: (2020)

Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming
por: Brashears, Caitlyn B., et al.
Publicado: (2020)

Exosomal miR-105-5p derived from bladder cancer stem cells targets for GPR12 to promote the malignancy of bladder cancer
por: Pan, Gaojian, et al.
Publicado: (2023)

METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
por: Xia, Peng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_84rmuic11om3iv42f7t31sctql